Radiotheranostics: Recent advancements and a strategy for future growth

Clicks: 1
ID: 309217
2024
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #144 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Radiotheranostics, injectable radiopharmaceuticals having anticancer activity, have advanced rapidly in the last decade. Although various formulations have been approved for human use, further radiopharmaceuticals are projected to be integrated into clinical practice within the next five years, potentially giving innovative therapy options for patients. Despite these advancements, other obstacles persist, such as logistics, supply chain, regulatory constraints, and education and training. This study intends to highlight recent advances in the area, inform practitioners about the value of radiotheranostics, and establish a framework for future development. Multidisciplinary methods to clinical trial design and therapy administration will be critical for the further development of this developing therapeutic modality.
Reference Key
imported_1761926679_6904de1740f67 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vivek Kumar, Durgesh Pal, Pradeep Kumar, Sanjay Kumar, Vivekanand Tiwari, Rahul Kumar
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2024
DOI
10.62896/ijpdd.1.11.3
URL
https://ijpdd.org/index.php/files/article/view/168
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.